On this page you will find documents and material from ESCAIDE 2020 which took place on 24-27 November, online. These include recordings and presentations from the plenary sessions, conference and communication materials.

Video playlist



Day 1, 24 November


Day 1 (24 November)


Introduction to ESCAIDE 2020


Preparation Fireside panel 1a

Abstract presentations viewing


Fireside Panel 1a (Live Q&A session) Moderated by: Ettore Severi


Topic: Food and waterborne diseases outbreaks


1. Outbreak of Yersinia enterocolitica in Norway, 2020, Trude M Lyngstad


2. A Campylobacter jejuni outbreak linked to contaminated pasteurized milk in Denmark, 2020: a matched case-control study, Luís Alves de Sousa


3. Nuts about salmonella: consumption of brazil nuts and nut bars identified as risk factor for Salmonella Typhimurium t5.6145 in case-control study, United Kingdom, May - July 2020, Ranya Mulchandani


4. An outbreak of nalidixic acid and ciprofloxacin resistant Salmonella Enteritidis linked to eggs from Poland, Austria, 2019, Lukasz Henszel


5. Investigation of an outbreak of ESBL- producing Salmonella Kentucky in humans linked to poultry in Malta, 2013-2020, Raquel Medialdea Carrera


Poster mingle



Side event: GOARN, 20 years supporting international outbreak response


Side event: Workshop epitweetr

Note: limited places available.


Preparation Fireside panel 1b

Abstract presentations viewing


Fireside Panel 1b (Live Q&A session) Moderated by: Therese Westrell


Topic: Food and waterborne diseases outbreaks (other)


6. Epidemiological investigation of eight cases of lethal encephalitis caused by newly detected zoonotic Borna disease virus 1 in Germany, 2019-2020, Kirsten Pörtner


7. Tracking the origin of Austrian human Brucellosis cases using whole genome sequencing, 2005-2019, Justine Schaeffer         


8. Molecular typing as a tool to investigate the national increase of cryptosporidiosis cases in Sweden autumn/winter 2019, Jessica Beser


9. Risk assessment of foodborne Hepatitis E virus in Italy, Ornella Moro


10. A Campylobacter outbreak warning tool in Denmark: (less) time, (more) place and person, Guido Benedetti

16.40-17.00 Interactive break

Side event: Career Compass 

Note: limited places available.


Day 2, 25 November


Day 2 (25 November)


Introduction to ESCAIDE 2020


Preparation Fireside panel 2a

Abstract presentations viewing


Fireside panel 2a (Live Q&A session) Moderated by: Erika Duffell


Topic: HIV, sexually transmitted infections and blood infections


11. CD4/CD8-ratio trajectories in ClinSurv, a large multicentre HIV-cohort study from Germany 1999-2018, Kirsten Pörtner


12. Low vaccination coverage for Human papillomavirus disease among men who have sex with men in France, 2019, Giuseppina Ortu


13. An Evaluation of Gram-negative Bloodstream Infections Surveillance across Hospital Trusts in East of England, 2019, Nastassya Lakshmi Chandra


14. Evaluation of the National Surveillance System for Notifiable Sexually Transmitted Infections, Portugal, 2015-2018, Héloïse Lucaccioni


Poster mingle


Side event: MediPIET


Preparation Fireside panel 2b

Abstract presentations viewing


Fireside panel 2b (Live Q&A session) Moderated by: Kari Johansen


Topic: Vaccine-preventable diseases


15. Brand-specific influenza vaccine effectiveness against laboratory-confirmed influenza in Europe – results from the DRIVE network 2019/20, Anke Stuurman


16. Vaccine effectiveness against influenza A(H1N1)pdm09, A(H3N2) and B: Results from the 2019/20 European I-MOVE primary care multicentre study, Esther Kissling


17. Healthcare provider knowledge of and barriers to pneumococcal vaccination in at risk adults: survey results in Ireland 2020, Niamh Bambury


18. Universal infant vaccination against hepatitis B: is the end of risk-group HBV vaccination for MSM approaching?, Maria Xiridou


Preparation Fireside panel 2c

Abstract presentations viewing


Fireside panel 2c (Live Q&A session) Moderated by: Angeliki Melidou


Topic: Influenza and other respiratory viruses


19. Excess hospitalizations associated with RSV among children under 5 years old in France from 2010 to 2018, Demont Clarisse


20. Burden of hospitalization due to respiratory syncytial virus (RSV)-very severe associated lower respiratory tract infection (VS-ALRI) in the first year of life in a major urban city, Lyon, France, Jean-sebastien Casalegno


21. Novel methods in the surveillance of influenza-like illness (ILI): exploration of data from the symptom assessment app Ada, Caoimhe Cawley


22. Supervised learning of syndromes from emergency department data to improve syndromic surveillance of influenza-like illness in Germany, Birte Wagner


Side event: EAN General Assembly 

Closed event


Day 3, 26 November 


Day 3 (26 November)

9.45-9.50 Introduction to ESCAIDE 2020


Message from ECDC Director Andrea Ammon

10.00-10.10 Message from ESCAIDE Scientific Committee Chair Mike Catchpole


Keynote session on COVID-19

Chaired by Mike Catchpole (ECDC) & Magdalena Rosińska (National Institute of Public Health - National Institute of Hygiene, Poland)

  • Speaker A1: George Fu Gao, China CDC
  • Speaker A2: Andrea Ammon, ECDC
  • Speaker A3: Maria van Kerkhove, WHO, Switzerland





Preparation Fireside panel 3a

Abstract presentations viewing


Fireside panel 3a (Live Q&A session) Moderated by:  Eeva Broberg


Topic: COVID-19 Serology and prevalence


23. The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A national seroprevalence study, June-July 2020, Patricia Garvey


24. SARS-CoV-2 prevalence and seroprevalence among healthcare workers in Belgian hospitals: preliminary results of a prospective cohort study, Laure Mortgat


25. Seroepidemiologic study to detect antibody-mediated immunity against SARS-CoV-2 among residents and healthcare workers in the city of Plovdiv, Bulgaria, weeks 21-24, 2020, Savina Stoitsova


26. Seroprevalence for SARS-CoV-2 and associated factors in the Rinkeby-Kista district of Stockholm, Sweden, 22–24 June 2020, Jessica Beser


Preparation Fireside panel 3b

Abstract presentations viewing


Fireside panel 3b (Live Q&A session) Moderated by: Tarik Derrough


Topic: COVID-19 response        


27. Changes in behaviour of the UK population due to COVID-19, March to June 2020, Sarah Foulkes


28. Community Engagement Interviews to Assess Feasibility of Shielding and Inform COVID-19 Response in IDP Camps in Nigeria, Emily Briskin


29. Establishing a COVID-19 Pandemic Severity Assessment surveillance system in Ireland - preliminary findings, Lisa Domegan


30. A traffic light model for infection prevention guidelines in Norwegian schools: experiences with adjusted levels of measures, COVID-19 pandemic, 2020, Tone Johansen


Preparation Fireside panel 3c

Abstract presentations viewing


Fireside panel 3c (Live Q&A session) Moderated by: Cornelia Adlhoch


Topic: COVID-19 Surveillance


31. Comparison of secondary attack rates resulting from asymptomatic, presymptomatic and symptomatic cases in a COVID-19 outbreak in Freising district, Germany, February-March 2020, Jennifer Bender


32. Role of returning travellers and control measures on the dynamics of COVID-19 in Bavaria, Stefanie Böhm


33. The COVID-19 epidemic in Spain: Characterisation of cases and risk factors for severe outcomes, Despina Pampaka


34. COVID-19: Determinants of Hospitalization, ICU admission and Death among 20,293  reported cases in Portugal, Vasco Ricoca Peixoto


Plenary B: Pandemic preparedness in times of COVID-19: how have pandemic preparedness plans contributed to responding to this global public health threat?

Chaired by Vicky Lefevre (ECDC) & Frode Forland (Norwegian Institute of Public Health)

  • Speaker B1: Devi Sridhar (University of Edinburgh, United Kingdom)
  • Speaker B2: Gabrielle Breugelmans (CEPI, Norway)
  • Speaker B3: Anders Tegnell (Public Health Agency, Sweden)
  • Speaker B4: Francesco Maraglino (Ministry of Health, Italy)






Poster mingle


Wrap-up session


Day 4, 27 November


Day 4 (27 November)


Introduction to ESCAIDE 2020


Interactive break


Plenary C: Magic bullet to control antimicrobial resistance (AMR): behaviour change or new technologies?

Chaired by Bojana Beović (University of Ljubljana Slovenia) & Bruno Coignard (Santé publique France)

  • Speaker C1: Esmita Charani (Imperial College London, United Kingdom)
  • Speaker C2: A.W. (Alex) Friedrich (University of Groningen, The Netherlands)
  • Speaker C3: Stephan Harbarth (Hôpitaux Universitaires de Genève, Switzerland)





Preparation Fireside panel 4a

Abstract presentations viewing


Fireside panel 4a (Live Q&A session) Moderated by: Pete Kinross


Topic: Antimicrobial resistance  


35. Comparison of phenotypic and genotypic antimicrobial susceptibility testing of VRE and ESBL isolates in Sweden, 2016-2018, Maximilian Riess


36. ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae carriage among veterinary healthcare workers in the Netherlands, Anouk Meijs


37. Estimating the impact of stewardship programmes on antibiotic consumption in EU. Evidence from the Eurobarometer for the years 2009-2018, Niccolò Stamboglis


38. CPE OXA-48 hospital ward outbreak in Ireland 2018-2019 - investigation of transmission patterns using social network analysis and genomics, Lisa Domegan and Carina Brehony


Preparation Fireside panel 4b

Abstract presentations viewing


Fireside panel 4b (Live Q&A session) Moderated by: Anastasia Pharris


Topic: COVID-19 Field epidemiology


39. Risk factors for outbreaks of COVID-19 in adult care facilities following hospital discharge: a national cohort analysis, James Adamson


40. Risk factors associated with an outbreak of COVID-19 in a meat-processing plant in Germany, April 2020, Iris Finci


41. Forgotten castles: What does serology tell us about the effect of the COVID-19 pandemic on care homes?, Anna Jeffery-Smith


42. Control of a COVID-19 outbreak with high case fatality ratio in Tirschenreuth district, Germany, March-May 2020, Michael Brandl


Preparation Fireside panel 4c


Abstract presentations viewing


Fireside panel 4c (Live Q&A session) Moderated by: John Kinsman


Topic: Global health and Emerging diseases


43. Early detection of cholera epidemics to support control in fragile states: delays and potential impacts, Ruwan Ratnayake        


44. Geographical distribution of human infective RNA viruses and their disappearance, Feifei Zhang


45. Strengthening country capacity for improving outbreak response to arboviral disease in West Africa, Giuseppina Ortu


46. Seroprevalence of Measles Antibodies in Tunisia: First findings of 2019 National Survey, Molka Osman


Plenary D: Field-epidemiology in the coming decade: where we have come from and where we should be going

Chaired by Frantiska Hruba (ECDC), Susan Hahné (RIVM) and Amrish Baidjoe (ICRC)

  • Speaker D1: Chikwe Ihekweazu (Nigeria CDC)
  • Speaker D2: Angela Hilmers (TEPHINET)
  • Speaker D3: Adam Roth (ECDC)





Poster mingle


Wrap-up session & Closing remarks by ECDC Director, Andrea Ammon


EAN virtual drinks

Closed event